3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
92
Phase 2
90
Phase 1/2
74
Phase 3
19
Phase EARLY_PHASE1
6
Phase 2/3
3
Phase NA
2
Phase 4
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Skin Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Melanoma
2
Carcinoma, Hepatocellular
2
Turcot syndrome
1
Recurrence
1
Prostatic Neoplasms
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Mouth Neoplasms
1
Malignant Ascites
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Small Cell
1
Carcinoma, Endometrioid
1
Carcinoma
1
Interventions
Blood Specimen Collection
11
Radiosurgery
7
Sentinel Lymph Node Biopsy
5
Early Intervention, Educational
5
Surveys and Questionnaires
4
Standard of Care
4
Practice Guidelines as Topic
4
Methods
4
Indocyanine Green
4
Educational Status
4
X-Rays
3
Surgical Procedures, Operative
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Immunotherapy
3
Cognitive Behavioral Therapy
3
Biopsy
3
pembrolizumab
2
montanide ISA 51
2
aldesleukin
2
Tomography, X-Ray Computed
2
Tomography, Emission-Computed
2
Specimen Handling
2
Radiotherapy
2
Radiation
2
Positron-Emission Tomography
2
Palliative Care
2
Observation
2
Interviews as Topic
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Melanoma
×
pembrolizumab
×
Clear all
NCT07436390
2026-03-02
MAK
Institute of Oncology Ljubljana
Phase NA
Completed
132 enrolled
NCT07422779
2026-02-20
MAK
Institute of Oncology Ljubljana
Phase NA
Recruiting
100 enrolled